April 25, 2023
Off we GO
This morning Insulet announced they had received FDA approval for the basal only system the Omnipod GO. Now we’ll state upfront that we don’t expect the GO to add materially to Insulet’s bottom line. This is really nothing against the GO it’s just we don’t believe in basal only systems such as the GO. Yet unlike other basal only systems the GO has some things going for it that the other systems don’t.
1. There is no patient interaction with the system once it’s on the body. According to the press . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.
